MOUNTAINSIDE — Kenneth Lane, president of BASF’s global catalysts division, has been appointed to serve on the Children’s Specialized Hospital Foundation Board of Trustees for the next three years. The hospital serves children affected by brain injury, spinal cord injury, premature birth, autism, developmental delays, and life-changing illnesses
The Board of Trustees at the Children’s Specialized Hospital Foundation governs, guides, and advocates for the hospital, patients, and families. The Board guides the foundation to secure new and continued levels of philanthropic support from a diverse donor constituency through a variety of gift and investment opportunities. While minimizing expenses and maximizing the positive impact that each gift has on the lives of special needs children.
Prior to his position at BASF, Mr. Lane served as senior vice president, BASF Isocyanates Europe, based in Brussels, Belgium. In this role he was accountable for this $2 billion business, whose operations span Europe, the Middle East and Africa.
Lane joined BASF in 2006, and, in the years since, has held senior-level management and strategic marketing positions in the United States and Europe.
“We’re so excited that Mr. Lane has joined our Board of Trustees and can share his expertise in strategic marketing with us,” said Philip Salerno III, president and chief development officer, Children’s Specialized Hospital Foundation.
Lane holds a bachelor of science in civil engineering from Clemson University (South Carolina) and a master of management from the University of Alabama (Huntsville).
Connect with NJTODAY.NET
Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!